Research Article

Safety and Prognostic Impacts of Ovarian Preservation during Radical Hysterectomy for Early-Stage Adenocarcinoma and Adenosquamous Cervical Cancer

Table 1

Characteristic comparison between patients aged <50 years with or without ovarian preservation.

CharacteristicsTotal ()OP ()Non-OP () value

Age41 (36, 45)38 (35, 42)45 (41, 47)<0.001
FIGO stage0.033
 IA225 (12.8)8 (7.4)a17 (19.3)
71 (36.2)44 (40.7)b27 (30.7)
100 (51.0)56 (51.9)a,b44 (50.0)
Histology0.550
 Adenocarcinoma167 (85.2)94 (87.0)73 (83.0)
 Adenosquamous29 (14.8)14 (13.0)15 (17.0)
LVSI0.566
 No169 (86.2)95 (88.0)74 (84.1)
 Yes27 (13.8)13 (12.0)14 (15.9)
Parametrial invasion0.349
 No186 (94.9)104 (96.3)82 (93.2)
 Yes10 (5.1)4 (3.7)6 (6.8)
LN metastasis0.703
 No189 (96.4)105 (97.2)84 (95.5)
 Yes7 (3.6)3 (2.8)4 (4.5)
Vaginal margin involvement1.000
 No192 (98.0)106 (98.1)86 (96.7)
 Yes4 (2.0)2 (1.9)2 (2.3)
DSI1.000
 No154 (78.6)85 (78.7)69 (78.4)
 Yes42 (21.4)23 (21.3)19 (21.6)
Type of surgery0.254
 Open193 (98.5)105 (97.2)88 (100)
 Laparoscopic3 (1.5)3 (2.8)0 (0)
Adjuvant treatment0.092
 No171 (87.2)99 (91.7)72 (81.8)
 RT19 (9.7)6 (5.6)13 (14.8)
 CCRT6 (3.1)3 (2.8)3 (3.4)
Year of treatment0.008
 1987-199956 (28.6)22 (20.4)34 (38.6)
 2000-2017140 (71.4)86 (79.6)54 (61.4)
Postoperative HRT<0.001
 No143 (73.0)93 (86.1)50 (56.8)
 Yes27 (13.8)6 (5.6)21 (23.9)
 Missing26 (13.2)9 (8.3)17 (19.3)
Recurrence0.712
 No173 (88.3)94 (87.0)79 (89.8)
 Yes23 (11.7)14 (13.0)9 (10.2)
Recurrent site0.933
 Locoregional16 (69.5)10 (71.4)6 (66.7)
 Distance5 (21.7)3 (21.4)2 (22.2)
 Combined2 (8.7)1 (7.1)1 (11.1)

Values are presented as number (%), median (IQR1-IQR3). FIGO: The International Federation of Gynecology and Obstetrics; OP: ovarian preservation; LVSI: lymph-vascular space invasion; LN: lymph node; DSI: deep stromal invasion; RT: radiotherapy; CCRT: concurrent chemoradiation; HRT: hormonal replacement therapy. a,bFIGO stage not having a superscript in common within clinicopathological characteristics differ significantly ( value < 0.05).